An OVID Health article by Ollie George Yesterday the UK Government announced a landmark UK-US pharmaceutical trade deal designed to safeguard medicines access and reinforce the UK’s position as a life sciences superpower. The deal delivers headline commitments that have been widely welcomed by industry: · Zero tariffs on pharmaceutical exports · A reduced VPAG …
The OVID team were proud to support Tillotts Pharma UK in launching the A Chronic Cost campaign in Parliament yesterday. Hosted by Baroness Young of Old Scone, the event shone a spotlight on the impact of prescription charges on people living with inflammatory bowel disease (IBD) in England. Featuring powerful insights from the IBD community, …
An OVID Health article by Anna Parnanen Recently, the Cell and Gene Therapy Catapult and the Advanced Therapy Treatment Centre (ATTC) network brought the ATMP community together for “Shaping a stronger UK ecosystem for advanced therapy clinical trials.” OVID Health acts as a secretariat to the Cell and Gene Collective (CGC), an alliance of five …
An OVID Health article by Carys Lloyd Earlier this week, the government unveiled the first UK-wide NHS league tables, ranking all 205 trusts in England on 30 metrics that included waiting times, financial health, and patient experience. Streeting hailed it as a ‘landmark’ moment, promising a new era of transparency designed to ‘empower’ patients in …
An OVID Health article by Ollie George Earlier this summer, the UK government unveiled an ambitious Life Sciences Sector Plan, aiming to position the country as a global leader in health innovation, clinical research, and life sciences investment. It was a bold vision – one that promised to harness the UK’s rich ecosystem of research institutions, …
An OVID Health article by David Talbot The Government is clearly committed to creating a more agile, proportionate and innovation-friendly regulatory system for the UK health and life sciences sector, but at what risk? When Labour sent a missive to leading regulators last Christmas, across a vast array of sectors, asking for them to come …
An OVID Health article by Anna Parnanen As England prepares its first men’s health strategy, women’s health risks deprioritisation – and not many seem to notice. In April 2025, the government launched a call for evidence to shape England’s first-ever men’s health strategy, representing an important and overdue recognition of the distinct health challenges men …
An OVID Health article by David Talbot The Government is launching its long-awaited 10-Year Plan for the NHS. Will it “fundamentally rewire” the health service, as the PM and Health Secretary will say later today? From National to Neighbourhood At the core of the 10-Year vision is to fundamentally remodel the NHS’ current behemothic, command …
Here’s our round-up of SXSW London insights at the conclusion of a packed festival-conference. While SXSW is not a health conference or a life sciences event, at OVID we’re health change makers (as are our clients)—so what better place to explore creative and cutting-edge innovations than at SXSW’s first outing outside of Texas around the …
The room was packed for OVID Health's recent breakfast event, Navigating the Future of the NHS, and no wonder – policy and government affairs professionals are navigating a constantly-changing, complex landscape. But will NHS reforms deliver better outcomes for patients, or just another layer of distraction? Here are four reflections in honour of our brilliant ...
We’re an award-winning global specialist healthcare communications consultancy, creators of the Patient Advocacy & Centricity Tracker tool and founders of the global Patient Partnership Index.
OVID Health is a trading name of Ovid Consulting Ltd (Company No. 11372061)
registered in England at B19, SBC House, Restmor Way, Wallington, SM6 7AH.
Site by XYCO
OVID Health is a trading name of Ovid Consulting Ltd (Company No. 11372061)
registered in England at B19, SBC House, Restmor Way, Wallington, SM6 7AH.
Site by XYCO
